L3VLUP
ProSign in

IART in the 13F filings

Integra Lifesciences Holdings Corp · CUSIP 457985208

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
31 Mar 2024
the date the book describes
Filed
24 May 2024
latest of these filings; the earliest 6 May 2024
Managers listing it
8
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q4 2023 and Q1 2024; 6 listed it in both
Shares listed
10,669,705
combined, among listed positions
Reported value
$378m
combined, at the quarter end

Among the 93 comparable managers: 7 buyers (opened or added shares) and 2 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing IART in Q1 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q4 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

8 of 8 holders

ActionFiling
Capital Research Global Investors5,918,981$210munder 0.1%Added+1,621,65514 May 2024 (the filing on sec.gov)
AllianceBernstein LP3,220,291$114munder 0.1%Added+494,78914 May 2024 (the filing on sec.gov)
Voloridge Investment Management LLC571,320$20m0.07%Added+260,99215 May 2024 (the filing on sec.gov)
Two Sigma Advisers LP566,300$20munder 0.1%Added+8,90015 May 2024 (the filing on sec.gov)
Tudor Investment Corp272,783$9.7m0.06%Addedn.a.15 May 2024 (the filing on sec.gov)
Bridgewater Associates LP66,620$2.4munder 0.1%Trimmed-9,75414 May 2024 (the filing on sec.gov)
Quantbot Technologies LP43,991$1.6m0.09%Addedn.a.6 May 2024 (the filing on sec.gov)
Maverick Capital Ltd9,419$334kunder 0.1%Added+76715 May 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q4 2023 to Q1 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
3 in Q3 2024 to 1 in Q2 2026

Tracked managers listing it, at least.

051015201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
IART by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20131$447kn.a.n.a.
Q3 20132$523kn.a.n.a.
Q4 20131$587kn.a.n.a.
Q1 20152$13mn.a.n.a.
Q2 20152$347mn.a.n.a.
Q3 20155$370mn.a.n.a.
Q4 20153$408mn.a.n.a.
Q1 20164$378mn.a.n.a.
Q2 20165$494mn.a.n.a.
Q3 20164$550mn.a.n.a.
Q4 20168$639mn.a.n.a.
Q1 20179$472mn.a.n.a.
Q2 20176$823mn.a.n.a.
Q3 20175$963mn.a.n.a.
Q4 20173$999mn.a.n.a.
Q1 20183$1.2bnn.a.n.a.
Q2 201810$1.7bnn.a.n.a.
Q3 20186$1.9bnn.a.n.a.
Q4 20187$1.1bnn.a.n.a.
Q1 20198$986mn.a.n.a.
Q2 20197$1.1bnn.a.n.a.
Q3 20195$1.1bnn.a.n.a.
Q4 20195$1.1bnn.a.n.a.
Q1 20207$855mn.a.n.a.
Q2 20205$892mn.a.n.a.
Q3 20206$992mn.a.n.a.
Q4 20206$1.4bnn.a.n.a.
Q1 20214$1.5bnn.a.n.a.
Q2 20216$1.5bnn.a.n.a.
Q3 20216$1.7bnn.a.n.a.
Q4 20216$1.6bnn.a.n.a.
Q1 20228$1.3bnn.a.n.a.
Q2 202210$969mn.a.n.a.
Q3 202214$702mn.a.n.a.
Q4 202211$946mn.a.n.a.
Q1 202311$864mn.a.n.a.
Q2 202312$492mn.a.n.a.
Q3 202313$481mn.a.n.a.
Q4 202310$530m56
Q1 20248$378m72
Q2 20246$212m34
Q3 20243$87m21
Q4 20243$60m22
Q1 20253$34m12
Q2 20252$2.8m12
Q3 20252$1.8m02
Q4 20251$662k1311
Q1 20261$679k1311
Q2 20261$1.8m1412

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

IART and LLY →IART and JNJ →IART and VRTX →Choose a stock to compare with IART →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own IART, latest filings →Back to the 13F Explorer →